Advair HFA Related Clinical Trials
A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS [Completed]
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS) [Recruiting]
MGR001 / Advair Diskus Local Equivalence Study in Asthma [Active, not recruiting]
The Effect on Depressive Symptoms in ECF Residents With COPD [Completed]
Atlantis Symbicort [Completed]
Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation [Completed]
The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD [Withdrawn]
Dose-Response of Salmeterol in Children [Completed]
Effects of AdvairŪ in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation [Completed]
Symbicort Onset of Action 1 [Completed]
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim [Completed]
Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENTŪ DISKUSŪ and ADVAIRŪ DISKUSŪ in Patients With Persistent Asthma 12 Years of Age and Older [Active, not recruiting]
Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics [Not yet recruiting]
Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep [Not yet recruiting]
Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial [Recruiting]
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma [Recruiting]
Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone) [Completed]
Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects [Completed]
Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair [Completed]
Study Of Allergic Rhinitis In Patients Who Also Have Asthma [Completed]
Symbicort Onset of Action 2 [Completed]
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate [Completed]
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID [Active, not recruiting]
Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo [Completed]
Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes [Active, not recruiting]
Non-invasive Measures of Distal Lung Disease in Asthmatics [Completed]
Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma [Active, not recruiting]
Best African American Response to Asthma Drugs [Recruiting]
Environmental Control as Add-on Therapy in Childhood Asthma [Not yet recruiting]
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma [Completed]
Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway [Completed]
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma [Completed]
Pharmacogenetics of b2-Agonists in Asthma. [Completed]
Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange [Completed]
Zileuton and Exhaled Nitric Oxide in Asthmatics [Completed]
Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers [Completed]
Study In Asthma Control [Terminated]
Advair Pediatric Once-Daily [Completed]
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program [Enrolling by invitation]
Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate [Completed]
Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma [Active, not recruiting]
Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy [Completed]
Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients [Completed]
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma [Recruiting]
Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets [Completed]
Sub-Sensitivity to Long-Acting Bronchodilators (LABA) [Completed]
Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
ADVAIR DISKUS (Fluticasone Propionate/Salmeterol) Versus SEREVENT DISKUS (Salmeterol) On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease [Terminated]
Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) [Completed]
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus [Completed]
Impact of Asthma Treatments on Daily Activities [Recruiting]
WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Completed]
Study Of Patients With Allergic Rhinitis And Asthma [Completed]
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma [Recruiting]
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) [Completed]
AdvairŪ DISKUSŪ Versus SereventŪ DISKUSŪ For Chronic Obstructive Pulmonary Disease Exacerbations [Completed]
Non-invasive Measures of Effects of Xolair in Asthma [Terminated]
Phase I Pharmacokinetic Study (SALBLOCK) [Completed]
AdvairŪ DISKUSŪ (Fluticasone Propionate/Salmeterol) Versus SereventŪ DISKUSŪ (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations [Completed]
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD [Withdrawn]
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD [Withdrawn]
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma [Completed]
Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Study of the Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations [Terminated]
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease [Completed]
Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALERŪ Device in Adult Patients With Persistent Asthma [Completed]
Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment [Completed]
Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation [Completed]
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population [Completed]
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies [Completed]
Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients [Recruiting]
Asthma Phenotypes in the Inner City [Active, not recruiting]
A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial [Recruiting]
Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations [Completed]
Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients [Completed]
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) [Completed]
GSK BHR Study (Sont - Second Study) [Completed]
GSK BHR Study (Sont) [Completed]
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) [Completed]
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus [Completed]
Effects on Small Airways of Two Long-term Extrafine Treatments in Asthma [Completed]
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol) [Completed]
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol) [Completed]
Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric) [Completed]
Fluticasone and Salmeterol in Allergic Rhinitis [Completed]
Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma [Completed]
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus [Recruiting]
Asthma Comparative Effectiveness Study [Completed]
A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease [Completed]
|